Examining emerging trends in palliative care utilization for malignant neoplasms with the highest mortality rates.

e24066 Background: Lung, colorectal, pancreatic, breast pharmaceutical companies, research organizations & HCOs was used. A total of 3,221,731 de-identified pts (pediatric, AYA & adult) was analyzed. The impact of palliative care use vs absence between 2009-2023 was compared in 4-year cohorts, with univariate & multivariate analyses. A p-value < 0.05 was deemed significant. Chi-square was employed to assess palliative care utilization or absence through the years for each group. Results: Analyzing Table 1, palliative care utilization was greater among Non-Hispanics and Whites, as evidenced by the mean. White pts consistently exhibit a higher use compared to other racial groups, but it declined between 2019-2023. The lowest use of palliative care was among Native Hawaiians, Native Americans, & Asians. Black, Latino, Other race, Unknown Race & unknown ethnicity pts accounted for about 50% of its use. Similarly, in most racial & ethnic groups a decline in its non-utilization was observed progressively. Based on the chi-square test, overall results show a significant P-value for all racial & ethnic groups through the years, except for white pts with a p-value of 0.1847. Conclusions: The study highlights disparities that exist in palliative care utilization among racial & ethnic groups. Despite increasing trend in its use, its utilization remains constant among minorities. These details are pivotal in advancing an inclusive healthcare that enhances end of life outcomes for all patients. Table: see text